Report cover image

Global Nicotine Gums and Lozenges Market Growth 2025-2031

Published Aug 08, 2025
Length 89 Pages
SKU # LPI20293220

Description

The global Nicotine Gums and Lozenges market size is predicted to grow from US$ 900 million in 2025 to US$ 1316 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Nicotine gums and lozenges are over-the-counter nicotine replacement therapy (NRT) products designed to help individuals quit smoking by reducing withdrawal symptoms and nicotine cravings. These products deliver controlled doses of nicotine to the bloodstream through oral absorption, offering a safer alternative to smoking by avoiding harmful tobacco-related toxins. Nicotine gums are chewed to release nicotine gradually, while lozenges dissolve in the mouth, providing a discreet and convenient option for smokers seeking to manage their addiction. Both forms are widely recommended as part of smoking cessation programs and have been shown to significantly increase the chances of quitting successfully when used correctly.

The market for nicotine gums and lozenges is driven by the increasing global awareness of the health risks associated with smoking and the growing demand for effective smoking cessation aids. Government initiatives, public health campaigns, and stricter regulations on tobacco products have encouraged more individuals to quit smoking, fueling the adoption of nicotine replacement therapies. Additionally, rising healthcare costs and the shift toward preventive healthcare further support market growth. The convenience, accessibility, and non-invasive nature of gums and lozenges make them popular choices among users, while ongoing product innovations, such as flavored and sugar-free options, continue to expand their appeal across diverse consumer segments.

LP Information, Inc. (LPI) ' newest research report, the “Nicotine Gums and Lozenges Industry Forecast” looks at past sales and reviews total world Nicotine Gums and Lozenges sales in 2024, providing a comprehensive analysis by region and market sector of projected Nicotine Gums and Lozenges sales for 2025 through 2031. With Nicotine Gums and Lozenges sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nicotine Gums and Lozenges industry.

This Insight Report provides a comprehensive analysis of the global Nicotine Gums and Lozenges landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nicotine Gums and Lozenges portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nicotine Gums and Lozenges market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nicotine Gums and Lozenges and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nicotine Gums and Lozenges.

This report presents a comprehensive overview, market shares, and growth opportunities of Nicotine Gums and Lozenges market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
2 mg/piece
4 mg/piece
Other

Segmentation by Application:
Withdrawal Clinics
Medical Practice
Individual Smokers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Novartis
Perrigo Company
Pfizer
Fertin Pharma
Johnson & Johnson
Cipla
Alkalon
GSK
Reynolds American
Dr. Reddy's Laboratories

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nicotine Gums and Lozenges market?

What factors are driving Nicotine Gums and Lozenges market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nicotine Gums and Lozenges market opportunities vary by end market size?

How does Nicotine Gums and Lozenges break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

89 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Tris (trimethylsilyl) Phosphate by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Tris (trimethylsilyl) Phosphate by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.